CURRICULUM VITAE

 

 

Name:                         ZUO-FENG ZHANG

 

Office Address:          Department of Epidemiology

UCLA School of Public Health

71-225 CHS, Box 951772

650 Charles E. Young Drive, South

Los Angeles, CA 90095-1772

(310) 825-8418 (Office)

(310) 206-6039 (Fax)

E-mail: ZFZHANG@UCLA.EDU

Education:

 

11/73 - 11/75               Yangzhou Secondary School of Hygiene, Yangzhou, China

Diploma in Public Health

 

09/78 - 08/83               Shanghai Medical University, Shanghai, China

                                    M.D. in Preventive Medicine

 

09/83 - 11/85               Shanghai Medical University, Department of Epidemiology, Shanghai, China

M.P.H. Program in Cancer Epidemiology

 

12/85 - 08/87               Shanghai Medical University, Department of Epidemiology, Shanghai, China

Ph.D. Candidate in Cancer Epidemiology

 

11/88 - 07/91               State University of New York at Buffalo

Memorial Roswell Park Cancer Institute, Buffalo, New York

Ph.D. Degree in Cancer Epidemiology

 

Postdoctoral Training:

 

09/87 - 08/88               Post-Doctoral Research Fellow in Cancer Epidemiology

Division of Descriptive Epidemiology & Division of Biostatistics

International Agency for Research on Cancer (IARC), Lyon, France

 

Positions and Appointments:

 

12/69 - 11/73               Bare-foot Doctor, Nantong Farm

 

11/75 - 08/78               Preventive Doctor/Infectious Disease Epidemiologist

Schistosomiasis Control Program

Anti-epidemic Station of Yangzhou Area, Yangzhou, China

 

07/81 - 02/82               Intern, Departments of Internal Medicine and Surgery

Shanghai No. 8 General Hospital, Shanghai, China

 

09/83 - 08/87               Physician Researcher, Cancer Epidemiology

Department of Epidemiology, School of Public Health

Shanghai Medical University, Shanghai, China

 

09/87 - 08/88               Research Fellow in Cancer Epidemiology

Divisions of Descriptive Epidemiology & Biostatistics

International Agency for Research on Cancer (IARC), Lyon, France

 

11/88 - 07/91               Research Instructor in Cancer Epidemiology

Department of Social & Preventive Medicine

State University of New York at Buffalo, Buffalo

 

08/91 - 03/96               Assistant Member

Memorial Sloan-Kettering Cancer Center, New York

 

Assistant Attending Epidemiologist

Memorial Hospital, New York

 

Assistant Professor of Epidemiology in Public Health

Cornell University Medical College, New York

 

04/97 - 07/97               Associate Member/Professor

Memorial Sloan-Kettering Cancer Center, New York

Associate Attending Epidemiologist Memorial Hospital, New York

 

07/97 - 06/99               Associate Professor

Department of Epidemiology, School of Public Health

University of California, Los Angeles (UCLA)

 

07/99 - Present            Professor

Department of Epidemiology, School of Public Health

University of California, Los Angeles (UCLA)

 

11/03 ¨C 06/05              Vice Chair

Department of Epidemiology, School of Public Health

University of California, Los Angeles (UCLA)

 

07/97 - Present            Member, Jonsson Comprehensive Cancer Center

University of California, Los Angeles (UCLA)

 

07/97 - Present            Scientific Director, UCLA Tumor Registry

University of California, Los Angeles (UCLA)

 

01/99 - Present            Director

UCLA Molecular Genetic Epidemiology Training Program

 

01/01 - Present            Co-Director of Epidemiology

Southern California Injury Research Center

 

01/01 - Present            Director

Molecular Epidemiology Planning Program

 

07/02 - Present            Co-Director, UCLA Center for Environment Genome

 

07/04 ¨C Present            Director, Alper Program of Environment Genomics

 

09/02 ¨C 08/2006          Member, Board of Directors, American College of Epidemiology

 

04/04 - Present            Director, Molecular Epidemiology and Carcinogenesis Program

UCLA Jonsson Comprehensive Cancer Center

 

07/02- Present             Senior Scientific Advisor, Jiangsu CDC

 

06/03 ¨C Present            Senior Academic Advisor, Zijiang CDC

 

12/04-01/05                 World Health Organization (WHO) Consultant, Western Pacific Region

Non-Communicable Disease Prevention and Control in People¡¯s Republic of China

 

Board Certification:  

 

American College of Epidemiology

 

Scientific and Medical Societies:

 

Member, Society of Epidemiologic Research

Member, American Society of Preventive Oncology

Faculty, New Investigator Workshop, ASPO (2000)

Member, International Epidemiological Association

Fellow, American College of Epidemiology (2000)

Board Member, Board of Directors, American College of Epidemiology

(2002-2006)

Member, Publication Committee, ACE (2000)

Member, International Genetic Epidemiology Society

Member, American Association of Cancer Research

 

University Committees:

 

Secretary, Faculty Executive Committee, School of Public Health Member, Faculty Executive Committee, School of Public Health

Member, Admission Committee, Department of Epidemiology

Member, Student Affairs Committee, School of Public Health

Member, the Cancer Prevention Consensus Panel, Cancer Prevention Curriculum

Member, The Cancer Committee at UCLA

Chair, Space Committee, Department of Epidemiology

Chair, Search Committee for Position in Gene-Environment Interaction

 

Grants and Research Support:

 

1998 - 2009                 Principal Investigator, T32 CA09142-21, Direct Cost: $1.8 M (5yr)

Cancer Epidemiology Training Program

NIH, National Institute of Cancer

 

2001 - 2008                 Principal Investigator (R01), P50 CA90833-01, Direct Cost: $1,3M Molecular Epidemiology of Lung Cancer

NIH, National Institute of Cancer

 

2007-2008                                     Co-Principal Investigator, D43 TW000013 (Supplement), Direct Cost: $100,000

International Training in Epidemiology Related to AIDS: HIV-AIDS-related Cancer in China¡±

NIH/Fogarty

                                                                                                     

2002 - 2008                 Co-Investigator, U01 CA 96134 (PI: Mao), Direct Cost: $990,000

Lung Cancer Chemo-prevention with Celecoxib in Ex-smokers.

NIH, NCI

 

 

Previous Grants:

 

1993 - 1996                 Principal Investigator, R01-ES06718, Direct Cost: $469,084

                                    Molecular Epidemiology of Bladder Cancer

                                    National Institute of Environmental Health Sciences

 

1997 - 1999                 Principal Investigator, R03-DK/CA53653, Direct Cost: $152, 000

                                    H. Pylori, Malnutrition, and Gastric Cancer

                                    National Institute of Diabetes, Digestive, and Kidney Diseases

 

1998 - 2000                 Principal Investigator, 2 P30 CA16042-24, Direct Cost: $150,000

                                    Molecular Epidemiology of Cancer

                                    Development Funds, Cancer Center Core Grant, NCI, NIH

 

1998 - 1999                 Principal Investigator, (No Number), Direct Cost: $29,954

                                    Molecular Epidemiology of Prostate Cancer

                                    Cancer Research Coordinating Committee, UC

 

1998 - 1999                 Principal Investigator, (No Number), Direct Cost: $25,775

                                    Interaction between Cancer Susceptibility and Tobacco Smoking on the

                                    Risk of Bladder Cancer.

                                    JCCC Seed Money Support

 

1998 - 1999                 Principal Investigator, (No Number), Direct Costs: $24,998

                                    Gene-nutrient interaction on the risk of prostate cancer.

                                    Carolan

 

1996 - 1997                 Principal Investigator, 2 P01 CA 29502, Direct Cost: $23,000

                                    Nutritional Factors for Cervical Neoplasia in Blacks

                                    NIH/NCI, Clinical Nutritional Research Unit

 

1995 - 2000                 Co-Investigator, 2 R01 CA 47538, Direct Cost $164,048

Cooperative Network for Evaluation of Markers of Urinary Bladder Cancer

                                    National Cancer Institute

 

1996 - 2001                 Co-Investigator, R01 DE12206, Direct Cost: $300,000

                                    Biomarkers of Oral Cancer Risk

                                    National Cancer Institute

 

1993 - 1995                 Principal Investigator, Direct Cost: $90,908

                                    Molecular/ Cellular Risk for Cervical Neoplasia in Blacks

                                    New York Community Trust

 

1992 - 1995                 Co-Principal Investigator, Direct Cost: $150,000

Inheritance & Genetic Alterations in Gastric & GE Junction Adenocarcinomas, Lawrence M. Gelb Foundation

 

1991 - 1995                 Co-Investigator, POI-CA32617-09Al, Direct Cost: $95,423

Smoking, Dieting & Other Risk Factors for Tobacco-Related Cancers National Institute of Cancer

 

1994 - 1995                 Co-Investigator, ($100,000)

The Identification of Susceptibility to Colorectal Cancer in Humans Institutional Funds

 

2001 - 2003                 Co-Investigator, CCRP0000732V-20186 (PI:Berek), Direct Cost: $366,831

Nutrient-Gene Interaction in Ovarian Cancer

California Cancer Research Program

 

2002 - 2007                 Principal Investigator, ES011667, Direct Cost: $450,000

Molecular Epidemiology and Gene-Environment Interaction

NIH, National Institute of Environment Health Sciences

 

2005-2007                                     Principal Investigator,  P50 CA92131-01A1 (PI: deKernion),

Direct Cost: $75,000

                                    Developing Project: Molecular Epidemiology of Prostate Cancer

                                    UCLA Prostate Cancer SPORE

 

2001 - 2006                 Co-Investigator, CA 091429 (PI: Braun), Direct Cost: $272,338

Consented High-Performance Index/Retrieval Path System, NIH, NCI

 

2001 - 2006                 Principal Investigator, DA03018 (PI: Tashkin), Direct Cost: $399,314 Pulmonary Effects of Habitual Use of Marijuana, NIH, NIDA

 

2002 - 2007                 Co-Investigator, U01 CA 96136 (PI: Belldegrun), Direct Cost: $980,518 Bladder Cancer Chemo-prevention with Green Tea in Ex-smokers.

NIH, NCI

 

1999 - 2006                 Co-Investigator, DA/CA 11386 (PI: Morgenstern), Direct Cost: $304,108

Marijuana Use and the Risks of Lung and Other Cancers NIH, NIDA

 

 

External Grant Review:

 

1996                            Reviewer, the Aids Related Research Study Section, NIH/DRG

1997                            Reviewer, Microbiological and Immunological Sciences Special Emphasis Panel ZRG5 ARRD(3)

1995                            Reviewer, Henry Ford Health System, Institutional Research Fund

2001                            Reviewer, EDC2, NIH

2002 - 2003                 Flight Attendant Medical Research Institute (FAMRI)

2002                            Reviewer, National Cancer Institute Special Emphasis Panel ZCA1 GRB- G (01), NIH

2003                            Reviewer, Special Emphasis Panel, ZCA1 GRB-G (01): SPORE in Ovarian and Breast Cancers, NCI

2003 - 2004                 Reviewer, the Health Services Research Fund (HSRF) and the Health and Health Services Research Fund (HHSRF), Hong Kong

2004                            Reviewer, ZRGI HOP-D (02)M: Special Emphasis Panel: Member Conflict: Cancer Epidemiology, NIH

2004                            Reviewer, World Cancer Research Fund International, London, UK

2004                            Reviewer, Epidemiology and Disease Control-2 (EDC-2) Study Section,

NIH

2005-2009                   Member, Cancer Epidemiology Study Section (EPIC), NCI/NIH

 

 

Honors and Awards:

 

1980 - 1983                 Awards for Excellent Medical Student each year by Shanghai Medical University

 

1983                            Rong-Lin's Prize (top 5/1000) by Shanghai Medical University

 

1985 - 1987                 Post-Graduate Awards each year for Excellency by Shanghai Medical University

1987 - 1988                 Post-Doctoral Research Fellowship by International Agency for Research on Cancer

 

1988                            Second-Class Prize of Scientific & Technology Awarded by the Ministry of Health for the Epidemiology of Cervical Cancer in Jingan County of China

 

1996                            The Harris P. Mosher Award by The American Laryngological, Rhinological and Ontological Society, aka The Triological Society

 

1996                            Honorary Senior Fellow, Department of Public Health and

Epidemiology, The University of Birmingham, Birmingham, U.K.

 

1998                            Delta Omega, the IOTA Chapter at the School of Public Health, UCLA

 

1999                            Honorary Guest Professor, School of Public Health, Beijing Medical University, China

 

1999